What are the indications and recommended dosage of loperamide 2 mg capsules for adults and children?

Loperamide 2 mg: Indications and Dosage

Loperamide 2 mg capsules are indicated for acute and chronic diarrhea in adults and children ≥2 years of age, but should NOT be used in children <18 years with acute diarrhea due to safety concerns. 1, 2

Key Contraindications and Safety Warnings

Critical safety point: Loperamide is absolutely contraindicated in children <2 years due to risks of respiratory depression and serious cardiac adverse reactions 2. The 2017 IDSA guidelines strongly recommend against using antimotility drugs like loperamide in children <18 years with acute diarrhea 1.

Avoid loperamide in ANY patient with:

• Inflammatory diarrhea or bloody diarrhea
• Fever with diarrhea (risk of toxic megacolon)
• Suspected infectious colitis
• Children/adolescents <18 years with acute diarrhea 1, 2

Indications

Adults and Adolescents ≥13 Years

• Acute watery diarrhea in immunocompetent patients (after adequate hydration) 1, 2
• Chronic diarrhea of various etiologies 2, 3

Pediatric Patients 2-12 Years

• Only for chronic diarrhea (acute diarrhea is contraindicated per IDSA guidelines) 1
• Ages 2-5 years: liquid formulation preferred over capsules 2

Dosing Regimens

Acute Diarrhea

Adults and Adolescents ≥13 years:

• Initial dose: 4 mg (two capsules)
• Maintenance: 2 mg (one capsule) after each unformed stool
• Maximum: 16 mg/day (eight capsules)
• Duration: Clinical improvement typically within 48 hours 2

Pediatric patients 2-12 years (chronic diarrhea only):

First day dosing:

• Ages 2-5 years (13-20 kg): 1 mg three times daily (3 mg total)
• Ages 6-8 years (20-30 kg): 2 mg twice daily (4 mg total)
• Ages 8-12 years (>30 kg): 2 mg three times daily (6 mg total)

Subsequent days: 1 mg/10 kg body weight after each loose stool, not exceeding first day maximum 2

Chronic Diarrhea

Adults:

• Initial: 4 mg followed by 2 mg after each unformed stool until controlled
• Maintenance: Reduce to individualized dose (average 4-8 mg/day in divided or single doses)
• Maximum: 16 mg/day
• Trial period: If no improvement after 10 days at 16 mg/day, unlikely to respond 2, 3

Critical Clinical Considerations

Fluid and electrolyte replacement is NOT optional - it must be provided alongside loperamide therapy. Loperamide is only an ancillary treatment and never substitutes for proper rehydration 1, 2.

High-risk populations requiring extreme caution:

• Children <3 years (serious adverse events including ileus, lethargy, death reported at 0.9% incidence) 4
• Malnourished or dehydrated patients
• Elderly patients on QT-prolonging medications (risk of cardiac arrhythmias) 2
• Patients with severe GI inflammation (enhanced systemic absorption and opioid toxicity risk) 5

Cardiac toxicity warning: Never exceed recommended doses - supratherapeutic doses cause QT prolongation, QRS widening, torsades de pointes, and potentially fatal arrhythmias 6. This has become increasingly recognized with loperamide misuse.

When to stop immediately:

• Development of abdominal distension
• Constipation
• Fever
• Bloody stools
• No improvement after 48 hours in acute diarrhea 2

Special Populations

• Elderly: No dose adjustment needed, but avoid in those on QT-prolonging drugs 2
• Renal impairment: No dose adjustment required 2
• Hepatic impairment: Use with caution due to increased systemic exposure 2